Addex Therapeutics (ADXN) Operating Leases (2022 - 2025)
Historic Operating Leases for Addex Therapeutics (ADXN) over the last 4 years, with Q3 2025 value amounting to $36207.2.
- Addex Therapeutics' Operating Leases fell 1417.78% to $36207.2 in Q3 2025 from the same period last year, while for Sep 2025 it was $36207.2, marking a year-over-year decrease of 1417.78%. This contributed to the annual value of $39429.9 for FY2024, which is 8971.57% down from last year.
- According to the latest figures from Q3 2025, Addex Therapeutics' Operating Leases is $36207.2, which was down 1417.78% from $37319.0 recorded in Q2 2025.
- Over the past 5 years, Addex Therapeutics' Operating Leases peaked at $3.8 million during Q1 2024, and registered a low of $21883.7 during Q2 2024.
- Moreover, its 4-year median value for Operating Leases was $42188.6 (2024), whereas its average is $360236.0.
- In the last 5 years, Addex Therapeutics' Operating Leases skyrocketed by 960188.38% in 2024 and then plummeted by 9904.26% in 2025.
- Quarter analysis of 4 years shows Addex Therapeutics' Operating Leases stood at $387322.2 in 2022, then increased by 0.22% to $388188.7 in 2023, then crashed by 89.8% to $39597.1 in 2024, then dropped by 8.56% to $36207.2 in 2025.
- Its last three reported values are $36207.2 in Q3 2025, $37319.0 for Q2 2025, and $36486.3 during Q1 2025.